136 related articles for article (PubMed ID: 9060042)
1. Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide.
Fowler CJ; Stenström A; Tiger G
Pharmacol Toxicol; 1997 Feb; 80(2):103-7. PubMed ID: 9060042
[TBL] [Abstract][Full Text] [Related]
2. Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.
Fowler CJ; Tiger G; Stenström A
J Pharmacol Exp Ther; 1997 Nov; 283(2):729-34. PubMed ID: 9353392
[TBL] [Abstract][Full Text] [Related]
3. Effects of anandamide on cannabinoid receptors in rat brain membranes.
Childers SR; Sexton T; Roy MB
Biochem Pharmacol; 1994 Feb; 47(4):711-5. PubMed ID: 8129747
[TBL] [Abstract][Full Text] [Related]
4. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
Mackie K; Devane WA; Hille B
Mol Pharmacol; 1993 Sep; 44(3):498-503. PubMed ID: 8371711
[TBL] [Abstract][Full Text] [Related]
5. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Ameri A; Wilhelm A; Simmet T
Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
8. Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH.
Holt S; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):237-44. PubMed ID: 12644895
[TBL] [Abstract][Full Text] [Related]
9. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
[TBL] [Abstract][Full Text] [Related]
10. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Stark S; Pacheco MA; Childers SR
Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.
Fowler CJ; Janson U; Johnson RM; Wahlström G; Stenström A; Norström K; Tiger G
Arch Biochem Biophys; 1999 Feb; 362(2):191-6. PubMed ID: 9989926
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Breivogel CS; Griffin G; Di Marzo V; Martin BR
Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
Guo J; Ikeda SR
Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.
Wiley JL; Ryan WJ; Razdan RK; Martin BR
Eur J Pharmacol; 1998 Aug; 355(2-3):113-8. PubMed ID: 9760024
[TBL] [Abstract][Full Text] [Related]
15. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
Smith PB; Compton DR; Welch SP; Razdan RK; Mechoulam R; Martin BR
J Pharmacol Exp Ther; 1994 Jul; 270(1):219-27. PubMed ID: 8035318
[TBL] [Abstract][Full Text] [Related]
17. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
De Petrocellis L; Melck D; Palmisano A; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8375-80. PubMed ID: 9653194
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
19. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
del Carmen García M; Adler-Graschinsky E; Celuch SM
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
